Low Incidence of Amyloid Related Imaging Abnormalities over 104 Weeks in a Phase 2 Study of Amyloid Anti‐Oligomer Agent ALZ‐801: Phase 2 Study Results in Biomarker Positive APOE4 Carriers with Early Alzheimer’s Disease (AD)

Authors

Luc Bracoud (ORCID: https://orcid.org/0000-0001-7175-8781)
John A. Hey (ORCID: https://orcid.org/0000-0002-5104-6231)
Niels D. Prins (ORCID: https://orcid.org/0000-0002-6297-7592)
Joyce Suhy
Martin Tolar (ORCID: https://orcid.org/0000-0002-3910-091X)
Jerome Barakos (ORCID: https://orcid.org/0000-0001-9117-2788)
Jakub Hort (ORCID: https://orcid.org/0000-0002-1080-3726)
Patrick Kesslak
Aidan Power
Susan Abushakra

Institutions

Netherlands Institute for Neuroscience (NL)
University Hospital in Motol (CZ)
Framingham State University (US)

Publication Details

Journal: Alzheimer s & Dementia
Published: 2024-12-01
DOI: https://doi.org/10.1002/alz.092653
Primary Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Low Incidence of Amyloid Related Imaging Abnormalities over 104 Weeks in a Phase 2 Study of Amyloid Anti‐Oligomer Agent ALZ‐801: Phase 2 Study Results in Biomarker Positive APOE4 Carriers with Early Alzheimer’s Disease (AD)

Luc Bracoud, John A. Hey, Niels D. Prins, Joyce Suhy et al.

Dec 1, 2024

Alzheimer s & Dementia

Amyloidosis: Diagnosis, Treatment, Outcomes

article

Low Incidence of Amyloid Related Imaging Abnormalities over 104 Weeks in a Phase 2 Study of Amyloid Anti‐Oligomer Agent ALZ‐801: Phase 2 Study Results in Biomarker Positive APOE4 Carriers with Early Alzheimer’s Disease (AD)

Luc Bracoud, John A. Hey, Niels D. Prins, Joyce Suhy, Martin Tolar, Jerome Barakos, Jakub Hort, Patrick Kesslak, Aidan Power, Susan Abushakra

December 1, 2024article en

Abstract

No abstract available for this paper.

Alzheimer s & DementiaVol. 20(S6)

Netherlands Institute for Neuroscience (NL), University Hospital in Motol (CZ), Framingham State University (US)

Good health and well-being

Openalex Percentile: Top 78%

Amyloidosis: Diagnosis, Treatment, Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.